From NETTER to PETTER: PSMA-Targeted Radioligand Therapy

J Nucl Med. 2017 Jan;58(1):9-10. doi: 10.2967/jnumed.116.184994. Epub 2016 Nov 17.

Authors

Matthias Eiber^{1

2}, Ken Herrmann³

Affiliations

¹ Department of Nuclear Medicine, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany matthias.eiber@gmx.de.
² Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, California; and.
³ Klinik für Nuklearmedizin, Universitätsklinikum Essen, Essen, Germany.

PMID: 27856632
DOI: 10.2967/jnumed.116.184994

No abstract available

Publication types

Comment

MeSH terms

Dipeptides
Heterocyclic Compounds, 1-Ring
Humans
Lutetium
Male
Prostate-Specific Antigen
Prostatic Neoplasms*

Substances

177Lu-PSMA-617
Dipeptides
Heterocyclic Compounds, 1-Ring
Lutetium
Prostate-Specific Antigen